Review during treatment of breast cancer

During treatment, the review of breast cancer patients is a crucial link in monitoring the effectiveness of the treatment and in the direction of subsequent rehabilitation.

Timing of review:

In general, the review is more frequent in the short term following the operation. For example, a review may be required every month during the first three months of the operation. This is because the body is in the recovery phase in the early post-operative stages and it is important to follow closely the abnormal activity of residual cancer cells. Over time, if the condition is stable, the interval between review may be duly extended, roughly every three to six months. However, specific schedules must strictly follow the doctor ‘ s instructions, as there are differences in the medical condition of each patient, his/her condition and the treatment used.

Item for review:

The first is breast ultrasound, which provides a clear view of the internal structure of the breast, as well as a look at the presence of new bulge formations, which is important for judging the recovery of the breast tissue and the signs of recurrence. Oncological markers are also essential, and numerical changes in markers such as CA153 can provide some indication of the activity of tumour cells. If a patient undergoes chemotherapy, there is also a need to regularly examine blood routines and to learn the count of white cells, red cells, plateboards, etc., as chemotherapy can have an impact on bone marrow blood function, leading to haematological abnormalities, which can be detected and implemented in a timely manner through regular blood tests. In addition, CT, liver ultrasound, etc., may be arranged for a full screening of cancer cells for transfer to other organs depending on the patient ‘ s circumstances.

Importance of review:

The review is like a “guideline” during treatment. Through regular reviews, doctors are able to obtain a timely and accurate picture of the patient ‘ s current state of health and assess the effectiveness of treatment programmes. If there are signs of recurrence or diversion, treatment strategies can be rapidly adapted to more effective interventions before the disease deteriorates. For patients, timely review can also give them a deeper heart and reduce fear and fear of unknown conditions.

Breast cancer patients must give high priority to the review process during their treatment, in strict compliance with the prescribed time and project, and in close cooperation with the doctor, in order to provide stronger guarantees for their rehabilitation.